Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal first quarter 2023 financial results for the three-month period ended November 30, 2022, revealing revenue of CA$10.3 million ($7.7 million), an 57% increase compared to Q1 2022.

Q1 2023 Financial Highlights

Other Highlights

Full story available on Benzinga.com